{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:27:12Z","timestamp":1793172432515,"version":"4.5.0"},"reference-count":247,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7,15]]},"abstract":"<jats:p>A panel of national experts was convened by the Infectious Diseases Society of America (IDSA) to update the 2005 guidelines for the treatment of skin and soft tissue infections (SSTIs). The panel's recommendations were developed to be concordant with the recently published IDSA guidelines for the treatment of methicillin-resistant Staphylococcus aureus infections. The focus of this guideline is the diagnosis and appropriate treatment of diverse SSTIs ranging from minor superficial infections to life-threatening infections such as necrotizing fasciitis. In addition, because of an increasing number of immunocompromised hosts worldwide, the guideline addresses the wide array of SSTIs that occur in this population. These guidelines emphasize the importance of clinical skills in promptly diagnosing SSTIs, identifying the pathogen, and administering effective treatments in a timely fashion.<\/jats:p>","DOI":"10.1093\/cid\/ciu296","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T22:04:37Z","timestamp":1403215477000},"page":"e10-e52","source":"Crossref","is-referenced-by-count":1816,"title":["Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America"],"prefix":"10.1093","volume":"59","author":[{"given":"Dennis L.","family":"Stevens","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Veterans Affairs, Boise, Idaho"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L.","family":"Bisno","sequence":"additional","affiliation":[{"name":"Medical Service, Miami Veterans Affairs Health Care System, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry F.","family":"Chambers","sequence":"additional","affiliation":[{"name":"San Francisco General Hospital, University of California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Patchen","family":"Dellinger","sequence":"additional","affiliation":[{"name":"Division of General Surgery, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie J. C.","family":"Goldstein","sequence":"additional","affiliation":[{"name":"University of California, Los Angeles, School of Medicine, and R. M. Alden Research Laboratory, Santa Monica, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherwood L.","family":"Gorbach","sequence":"additional","affiliation":[{"name":"Department of Community Health, Tufts University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan V.","family":"Hirschmann","sequence":"additional","affiliation":[{"name":"Medical Service, Puget Sound Veterans Affairs Medical Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon L.","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose G.","family":"Montoya","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Wade","sequence":"additional","affiliation":[{"name":"Geisinger Health System, Geisinger Cancer Institute, Danville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,7,15]]},"reference":[{"key":"2020120907532979700_CIU296C1","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"2020120907532979700_CIU296C2","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"2020120907532979700_CIU296C3","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \u201cquality of evidence\u201d and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"2020120907532979700_CIU296C4","doi-asserted-by":"crossref","first-page":"a744","DOI":"10.1136\/bmj.a744","article-title":"Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive","volume":"337","author":"Jaeschke","year":"2008","journal-title":"BMJ"},{"key":"2020120907532979700_CIU296C5","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3201\/eid1509.081228","article-title":"Trends in US hospital admissions for skin and soft tissue infections","volume":"15","author":"Edelsberg","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"2020120907532979700_CIU296C6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.annemergmed.2007.12.004","article-title":"Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus","volume":"51","author":"Pallin","year":"2008","journal-title":"Ann Emerg Med"},{"key":"2020120907532979700_CIU296C7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1086\/605434","article-title":"Epidemiology of dermatitis and skin infections in United States physicians\u2019 offices, 1993\u20132005","volume":"49","author":"Pallin","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C8","article-title":"Committee to Advise the Public Health Service on Clinical Practice Guidelines, United States. Department of Health and Human Services. Clinical practice guidelines: directions for a new program","author":"Field","year":"1990"},{"key":"2020120907532979700_CIU296C9","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1136\/bmj.39504.506319.80","article-title":"Incorporating considerations of resources use into grading recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"2020120907532979700_CIU296C10","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","article-title":"Grading quality of evidence and strength of recommendations for diagnostic tests and strategies","volume":"336","author":"Schunemann","year":"2008","journal-title":"BMJ"},{"key":"2020120907532979700_CIU296C11","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1093\/cid\/cis370","article-title":"IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults","volume":"54","author":"Chow","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C12","first-page":"42","article-title":"Impetigo: etiology and therapy","volume":"22","author":"Hirschmann","year":"2002","journal-title":"Curr Clin Top Infect Dis"},{"key":"2020120907532979700_CIU296C13","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1365-2133.2007.08197.x","article-title":"Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo","volume":"157","author":"Durupt","year":"2007","journal-title":"Br J Dermatol"},{"key":"2020120907532979700_CIU296C14","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1365-2133.2008.08485.x","article-title":"Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial","volume":"158","author":"Koning","year":"2008","journal-title":"Br J Dermatol"},{"key":"2020120907532979700_CIU296C15","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/597770","article-title":"A cluster of ecthyma outbreaks caused by a single clone of invasive and highly infective Streptococcus pyogenes","volume":"48","author":"Wasserzug","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C16","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJMoa055356","article-title":"Methicillin-resistant S. aureus infections among patients in the emergency department","volume":"355","author":"Moran","year":"2006","journal-title":"N Engl J Med"},{"key":"2020120907532979700_CIU296C17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.annemergmed.2009.03.014","article-title":"Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient","volume":"55","author":"Duong","year":"2010","journal-title":"Ann Emerg Med"},{"key":"2020120907532979700_CIU296C18","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1128\/AAC.00377-07","article-title":"Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection","volume":"51","author":"Rajendran","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2020120907532979700_CIU296C19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archderm.134.1.49","article-title":"Bacteriology of inflamed and uninflamed epidermal inclusion cysts","volume":"134","author":"Diven","year":"1998","journal-title":"Arch Dermatol"},{"key":"2020120907532979700_CIU296C20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.annemergmed.2010.11.021","article-title":"A randomized controlled trial of incision and drainage versus ultrasonographically guided needle aspiration for skin abscesses and the effect of methicillin-resistant Staphylococcus aureus","volume":"57","author":"Gaspari","year":"2011","journal-title":"Ann Emerg Med"},{"key":"2020120907532979700_CIU296C21","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/bjs.1800640410","article-title":"The treatment of acute superficial abscesses: a prospective clinical trial","volume":"64","author":"Macfie","year":"1977","journal-title":"Br J Surg"},{"key":"2020120907532979700_CIU296C22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0196-0644(85)80727-7","article-title":"Treatment of cutaneous abscess: a double-blind clinical study","volume":"14","author":"Llera","year":"1985","journal-title":"Ann Emerg Med"},{"key":"2020120907532979700_CIU296C23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1553-2712.2009.00409.x","article-title":"Routine packing of simple cutaneous abscesses is painful and probably unnecessary","volume":"16","author":"O'Malley","year":"2009","journal-title":"Acad Emerg Med"},{"key":"2020120907532979700_CIU296C24","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(70)92754-6","article-title":"Antibiotics in surgical treatment of septic lesions","volume":"1","author":"Rutherford","year":"1970","journal-title":"Lancet"},{"key":"2020120907532979700_CIU296C25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.annemergmed.2010.03.002","article-title":"Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection","volume":"56","author":"Schmitz","year":"2010","journal-title":"Ann Emerg Med"},{"key":"2020120907532979700_CIU296C26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","article-title":"Hidradenitis suppurativa: a comprehensive review","volume":"60","author":"Alikhan","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"2020120907532979700_CIU296C27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.suc.2009.09.006","article-title":"Evaluation and management of pilonidal disease","volume":"90","author":"Humphries","year":"2010","journal-title":"Surg Clin North Am"},{"key":"2020120907532979700_CIU296C28","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1001\/jama.1988.03410180090035","article-title":"Prevention of recurrent staphylococcal skin infections with low-dose oral clindamycin therapy","volume":"260","author":"Klempner","year":"1988","journal-title":"JAMA"},{"key":"2020120907532979700_CIU296C29","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1001\/archinte.1996.00040041109010","article-title":"A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection","volume":"156","author":"Raz","year":"1996","journal-title":"Arch Intern Med"},{"key":"2020120907532979700_CIU296C30","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1086\/523273","article-title":"Does nasal colonization or mupirocin treatment affect recurrence of methicillin-resistant Staphylococcus aureus skin and skin structure infections?","volume":"28","author":"Rahimian","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2020120907532979700_CIU296C31","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1128\/AAC.01086-06","article-title":"Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial","volume":"51","author":"Ellis","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2020120907532979700_CIU296C32","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1086\/657136","article-title":"Chlorhexidine-impregnated cloths to prevent skin and soft-tissue infection in Marine recruits: a cluster-randomized, double-blind, controlled effectiveness trial","volume":"31","author":"Whitman","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2020120907532979700_CIU296C33","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1086\/517503","article-title":"Successful termination of a furunculosis outbreak due to lukS-lukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002\u20132005","volume":"44","author":"Wiese-Posselt","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C34","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/cid\/cir919","article-title":"Household versus individual approaches to eradication of community-associated Staphylococcus aureus in children: a randomized trial","volume":"54","author":"Fritz","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C35","doi-asserted-by":"crossref","first-page":"163 e1","DOI":"10.1016\/j.jaad.2012.03.024","article-title":"Lower limb cellulitis and its mimics: part I. Lower limb cellulitis","volume":"67","author":"Hirschmann","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"2020120907532979700_CIU296C36","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/bmj.318.7198.1591","article-title":"Risk factors for erysipelas of the leg (cellulitis): case-control study","volume":"318","author":"Dupuy","year":"1999","journal-title":"BMJ"},{"key":"2020120907532979700_CIU296C37","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1086\/497127","article-title":"Risk factors for acute cellulitis of the lower limb: a prospective case-control study","volume":"41","author":"Bjornsdottir","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C38","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1086\/313525","article-title":"Cost-effectiveness of blood cultures for adult patients with cellulitis","volume":"29","author":"Perl","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1001\/archinte.1986.00360140113016","article-title":"Microbiologic evaluation of cutaneous cellulitis in adults","volume":"146","author":"Hook","year":"1986","journal-title":"Arch Intern Med"},{"key":"2020120907532979700_CIU296C40","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1001\/archinte.1990.00390200091017","article-title":"The optimum use of needle aspiration in the bacteriologic diagnosis of cellulitis in adults","volume":"150","author":"Sachs","year":"1990","journal-title":"Arch Intern Med"},{"key":"2020120907532979700_CIU296C41","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2133.1985.tb15264.x","article-title":"The value of bacteriology and serology in the diagnosis of cellulitis and erysipelas","volume":"112","author":"Leppard","year":"1985","journal-title":"Br J Dermatol"},{"key":"2020120907532979700_CIU296C42","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1001\/archinte.1988.00380110091019","article-title":"Influence of underlying disease process on the utility of cellulitis needle aspirates","volume":"148","author":"Kielhofner","year":"1988","journal-title":"Arch Intern Med"},{"key":"2020120907532979700_CIU296C43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/00365548909037882","article-title":"The etiology of bacterial cellulitis as determined by fine-needle aspiration","volume":"21","author":"Sigurdsson","year":"1989","journal-title":"Scand J Infect Dis"},{"key":"2020120907532979700_CIU296C44","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1128\/JCM.26.3.401-404.1988","article-title":"Value of needle aspiration in bacteriologic diagnosis of cellulitis in adults","volume":"26","author":"Newell","year":"1988","journal-title":"J Clin Microbiol"},{"key":"2020120907532979700_CIU296C45","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1001\/archderm.1996.03890310134030","article-title":"Value of fine-needle aspiration in infectious cellulitis","volume":"132","author":"Lebre","year":"1996","journal-title":"Arch Dermatol"},{"key":"2020120907532979700_CIU296C46","first-page":"45","article-title":"Microbiology of adult cellulitis","volume":"26","author":"Lutomski","year":"1988","journal-title":"J Fam Pract"},{"key":"2020120907532979700_CIU296C47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/archinte.1989.00390020039008","article-title":"Quantitative cultures of biopsy specimens from cutaneous cellulitis","volume":"149","author":"Duvanel","year":"1989","journal-title":"Arch Intern Med"},{"key":"2020120907532979700_CIU296C48","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-4362.1990.tb04833.x","article-title":"Erysipelas","volume":"29","author":"Chartier","year":"1990","journal-title":"Int J Dermatol"},{"key":"2020120907532979700_CIU296C49","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/clinids\/23.5.1091","article-title":"Erysipelas: clinical and bacteriologic spectrum and serological aspects","volume":"23","author":"Eriksson","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C50","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MD.0b013e3181e8d635","article-title":"The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation","volume":"89","author":"Jeng","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"2020120907532979700_CIU296C51","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1001\/archderm.1987.01660280070025","article-title":"Early detection of streptococcal group antigens in skin samples by latex particle agglutination","volume":"123","author":"Bernard","year":"1987","journal-title":"Arch Dermatol"},{"key":"2020120907532979700_CIU296C52","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1001\/archderm.1989.01670180051004","article-title":"Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique","volume":"125","author":"Bernard","year":"1989","journal-title":"Arch Dermatol"},{"key":"2020120907532979700_CIU296C53","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/clinids\/23.5.1162","article-title":"Association of athlete's foot with cellulitis of the lower extremities: diagnostic value of bacterial cultures of ipsilateral interdigital space samples","volume":"23","author":"Semel","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C54","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1984.03340320035023","article-title":"Recurrent cellulitis after coronary bypass surgery. Association with superficial fungal infection in saphenous venectomy limbs","volume":"251","author":"Baddour","year":"1984","journal-title":"JAMA"},{"key":"2020120907532979700_CIU296C55","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1086\/313467","article-title":"Anal colonization of group G beta-hemolytic streptococci in relapsing erysipelas of the lower extremity","volume":"29","author":"Eriksson","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C56","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF01645222","article-title":"The course, costs and complications of oral versus intravenous penicillin therapy of erysipelas","volume":"12","author":"Jorup-Ronstrom","year":"1984","journal-title":"Infection"},{"key":"2020120907532979700_CIU296C57","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/archinte.164.15.1669","article-title":"Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis","volume":"164","author":"Hepburn","year":"2004","journal-title":"Arch Intern Med"},{"key":"2020120907532979700_CIU296C58","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/656431","article-title":"Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship","volume":"51","author":"Jenkins","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C59","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/cid\/cit122","article-title":"Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial","volume":"56","author":"Pallin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C60","first-page":"177","article-title":"Rapid resolution of cellulitis in patients managed with combination antibiotic and anti-inflammatory therapy","volume":"75","author":"Dall","year":"2005","journal-title":"Cutis"},{"key":"2020120907532979700_CIU296C61","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/00365549709011834","article-title":"Antibiotic and prednisolone therapy of erysipelas: a randomized, double blind, placebo-controlled study","volume":"29","author":"Bergkvist","year":"1997","journal-title":"Scand J Infect Dis"},{"key":"2020120907532979700_CIU296C62","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/003655498750003708","article-title":"Relapse of erysipelas following treatment with prednisolone or placebo in addition to antibiotics: a 1-year follow-up","volume":"30","author":"Bergkvist","year":"1998","journal-title":"Scand J Infect Dis"},{"key":"2020120907532979700_CIU296C63","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/archinte.168.10.1034","article-title":"Use of corticosteroids in treating infectious diseases","volume":"168","author":"McGee","year":"2008","journal-title":"Arch Intern Med"},{"key":"2020120907532979700_CIU296C64","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1468-3083.2006.01657.x","article-title":"Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands","volume":"20","author":"Goettsch","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2020120907532979700_CIU296C65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF01650206","article-title":"Recurrent erysipelas: predisposing factors and costs of prophylaxis","volume":"15","author":"Jorup-Ronstrom","year":"1987","journal-title":"Infection"},{"key":"2020120907532979700_CIU296C66","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archinte.167.7.709","article-title":"A predictive model of recurrent lower extremity cellulitis in a population-based cohort","volume":"167","author":"McNamara","year":"2007","journal-title":"Arch Intern Med"},{"key":"2020120907532979700_CIU296C67","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00000441-200612000-00002","article-title":"Risk factors for recurrent lower extremity cellulitis in a U.S. Veterans Medical Center population","volume":"332","author":"Lewis","year":"2006","journal-title":"Am J Med Sci"},{"key":"2020120907532979700_CIU296C68","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1469-0691.2009.02906.x","article-title":"Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: a prospective case-control study","volume":"16","author":"Karppelin","year":"2010","journal-title":"Clin Microbiol Infect"},{"key":"2020120907532979700_CIU296C69","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1365-2133.2006.07419.x","article-title":"Oedema as a risk factor for multiple episodes of cellulitis\/erysipelas of the lower leg: a series with community follow-up","volume":"155","author":"Cox","year":"2006","journal-title":"Br J Dermatol"},{"key":"2020120907532979700_CIU296C70","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1439-0353.2004.03028.x","article-title":"Recurrent erysipelas: risk factors","volume":"2","author":"Pavlotsky","year":"2004","journal-title":"J Dtsch Dermatol Ges"},{"key":"2020120907532979700_CIU296C71","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000096913","article-title":"Recurrent erysipelas: 47 cases","volume":"214","author":"Leclerc","year":"2007","journal-title":"Dermatology"},{"key":"2020120907532979700_CIU296C72","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF01728920","article-title":"Antibiotic prophylaxis in recurrent erysipelas","volume":"21","author":"Sjoblom","year":"1993","journal-title":"Infection"},{"key":"2020120907532979700_CIU296C73","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0163-4453(91)90898-3","article-title":"Long-term antimicrobial therapy in the prevention of recurrent soft-tissue infections","volume":"22","author":"Kremer","year":"1991","journal-title":"J Infect"},{"key":"2020120907532979700_CIU296C74","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1086\/513752","article-title":"Role of benzathine penicillin G in prophylaxis for recurrent streptococcal cellulitis of the lower legs","volume":"25","author":"Wang","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C75","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1468-3083.2006.01648.x","article-title":"Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study","volume":"20","author":"Vignes","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2020120907532979700_CIU296C76","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1206300","article-title":"Penicillin to prevent recurrent leg cellulitis","volume":"368","author":"Thomas","year":"2013","journal-title":"N Engl J Med"},{"key":"2020120907532979700_CIU296C77","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1056\/NEJM199102073240604","article-title":"Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I","volume":"324","author":"Brennan","year":"1991","journal-title":"N Engl J Med"},{"key":"2020120907532979700_CIU296C78","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/501620","article-title":"Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee","volume":"20","author":"Mangram","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"suppl 2","key":"2020120907532979700_CIU296C79","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1086\/321860","article-title":"Surgical site infection (SSI) rates in the United States, 1992-1998: the National Nosocomial Infections Surveillance System basic SSI risk index","volume":"33","author":"Gaynes","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C80","volume-title":"Approach to the patient with postoperative fever","author":"Dellinger","year":"2004","edition":"3rd ed"},{"key":"2020120907532979700_CIU296C81","first-page":"161","article-title":"The effective period of preventive antibiotic action in experimental incisions and dermal lesions","volume":"50","author":"Burke","year":"1961","journal-title":"Surgery"},{"key":"2020120907532979700_CIU296C82","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199201303260501","article-title":"The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection","volume":"326","author":"Classen","year":"1992","journal-title":"N Engl J Med"},{"key":"2020120907532979700_CIU296C83","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/00000658-197906000-00004","article-title":"Prophylactic and preventive antibiotic therapy: timing, duration and economics","volume":"189","author":"Stone","year":"1979","journal-title":"Ann Surg"},{"key":"2020120907532979700_CIU296C84","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/clinids\/18.3.422","article-title":"Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America","volume":"18","author":"Dellinger","year":"1994","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C85","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1086\/421095","article-title":"Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project","volume":"38","author":"Bratzler","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C86","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1445-2197.1998.tb04785.x","article-title":"Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review","volume":"68","author":"McDonald","year":"1998","journal-title":"Aust N Z J Surg"},{"key":"2020120907532979700_CIU296C87","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/SLA.0b013e3181ad5fca","article-title":"Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors","volume":"250","author":"Steinberg","year":"2009","journal-title":"Ann Surg"},{"key":"2020120907532979700_CIU296C88","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1086\/512192","article-title":"Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor","volume":"44","author":"van Kasteren","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C89","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/jama.1982.03320350052030","article-title":"Toxic shock syndrome associated with surgical wound infections","volume":"247","author":"Bartlett","year":"1982","journal-title":"JAMA"},{"key":"2020120907532979700_CIU296C90","first-page":"130","article-title":"Postoperative toxic shock syndrome","volume":"24","author":"Raab","year":"1995","journal-title":"Am J Orthop (Belle Mead NJ)"},{"key":"2020120907532979700_CIU296C91","volume-title":"Principles and practice of infectious diseases","author":"Mandell","year":"1995","edition":"4th ed"},{"key":"2020120907532979700_CIU296C92","volume-title":"Wound infections: epidemiology and clinical characteristics","author":"Cruse","year":"1988"},{"key":"2020120907532979700_CIU296C93","volume-title":"Surgical wound infections: surveillance for quality improvement","author":"Lee","year":"1995"},{"key":"2020120907532979700_CIU296C94","volume-title":"Review for surgery: scientific principles and practice","author":"DeLucia","year":"1993"},{"key":"2020120907532979700_CIU296C95","volume-title":"The biologic basis of modern surgical practice","author":"Townsend","year":"2001"},{"key":"2020120907532979700_CIU296C96","first-page":"8","article-title":"Hospital Infections Chapter 817","author":"Dellinger","year":"2012"},{"key":"2020120907532979700_CIU296C97","first-page":"171","volume-title":"Surgical infections and choice of antibiotics","author":"Dellinger","year":"2001"},{"key":"2020120907532979700_CIU296C98","volume-title":"Wound infections: epidemiology and clinical characteristics. Surgical infectious diseases","author":"Howard","year":"1988","edition":"2nd ed"},{"key":"2020120907532979700_CIU296C99","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0163-4453(86)92118-3","article-title":"The value of adjuvant systemic antibiotic therapy in localised wound infections among hospital patients: a comparative study","volume":"13","author":"Huizinga","year":"1986","journal-title":"J Infect"},{"key":"2020120907532979700_CIU296C100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.7326\/0003-4819-87-2-145","article-title":"Cutaneous abscesses. Anaerobic and aerobic bacteriology and outpatient management","volume":"87","author":"Meislin","year":"1977","journal-title":"Ann Intern Med"},{"key":"2020120907532979700_CIU296C101","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1001\/archsurg.141.9.850","article-title":"Inappropriate antibiotic use in soft tissue infections","volume":"141","author":"Paydar","year":"2006","journal-title":"Arch Surg"},{"key":"2020120907532979700_CIU296C102","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0196-0644(97)70354-8","article-title":"Incision and drainage of cutaneous abscesses is not associated with bacteremia in afebrile adults","volume":"29","author":"Bobrow","year":"1997","journal-title":"Ann Emerg Med"},{"key":"2020120907532979700_CIU296C103","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archsurg.1990.01410230039007","article-title":"Aerobic and anaerobic bacteriology of wounds and cutaneous abscesses","volume":"125","author":"Brook","year":"1990","journal-title":"Arch Surg"},{"key":"2020120907532979700_CIU296C104","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0196-0644(86)80577-7","article-title":"Pathogen identification of abscesses and cellulitis","volume":"15","author":"Meislin","year":"1986","journal-title":"Ann Emerg Med"},{"key":"2020120907532979700_CIU296C105","volume-title":"Postoperative wound infection","author":"Dellinger","year":"2001","edition":"2nd ed"},{"key":"2020120907532979700_CIU296C106","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1001\/jama.1970.03170100059017","article-title":"Rare complications with intravenous hyperosmotic alimentation","volume":"211","author":"Wyrick","year":"1970","journal-title":"JAMA"},{"key":"2020120907532979700_CIU296C107","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/0002-9610(77)90283-5","article-title":"Bacteriology of necrotizing fasciitis","volume":"134","author":"Giuliano","year":"1977","journal-title":"Am J Surg"},{"key":"2020120907532979700_CIU296C108","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa042683","article-title":"Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles","volume":"352","author":"Miller","year":"2005","journal-title":"N Engl J Med"},{"key":"2020120907532979700_CIU296C109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198907063210101","article-title":"Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A","volume":"321","author":"Stevens","year":"1989","journal-title":"N Engl J Med"},{"key":"2020120907532979700_CIU296C110","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(94)90629-7","article-title":"Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features","volume":"344","author":"Chelsom","year":"1994","journal-title":"Lancet"},{"key":"2020120907532979700_CIU296C111","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1086\/511638","article-title":"Necrotizing soft-tissue infection: diagnosis and management","volume":"44","author":"Anaya","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C112","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00006454-199912000-00014","article-title":"Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection","volume":"18","author":"Zimbelman","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"2020120907532979700_CIU296C113","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/01.SMJ.0000051060.95210.9A","article-title":"Invasive group A streptococcal infections in Florida","volume":"96","author":"Mulla","year":"2003","journal-title":"South Med J"},{"key":"2020120907532979700_CIU296C114","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1086\/426025","article-title":"Community-based surveillance in the united states of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons","volume":"39","author":"Tanz","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C115","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/jac\/dkq006","article-title":"Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008)","volume":"65","author":"Ardanuy","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"2020120907532979700_CIU296C116","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MOL.0b013e328344780b","article-title":"Catching up with important players in atherosclerosis: type I interferons and neutrophils","volume":"22","author":"Noels","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"2020120907532979700_CIU296C117","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/01.inf.0000256761.10463.29","article-title":"Macrolide resistance and emm type distribution of invasive pediatric group A streptococcal isolates: three-year prospective surveillance from a children's hospital","volume":"26","author":"Jaggi","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"2020120907532979700_CIU296C118","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1086\/376652","article-title":"Dilemmas in the treatment of invasive Streptococcus pyogenes infections","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C119","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/515199","article-title":"Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome\u2014a comparative observational study. The Canadian Streptococcal Study Group","volume":"28","author":"Kaul","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/376630","article-title":"Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial","volume":"37","author":"Darenberg","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C121","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0039-6109(16)46485-6","article-title":"Fournier's gangrene","volume":"74","author":"Laucks","year":"1994","journal-title":"Surg Clin North Am"},{"key":"2020120907532979700_CIU296C122","first-page":"77","article-title":"Fournier's gangrene in Nigeria: a review of 21 consecutive patients","volume":"85","author":"Eke","year":"2000","journal-title":"Int Surg"},{"key":"2020120907532979700_CIU296C123","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0163-4453(94)90530-4","article-title":"Tropical pyomyositis","volume":"29","author":"Sissolak","year":"1994","journal-title":"J Infect"},{"key":"2020120907532979700_CIU296C124","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1086\/507637","article-title":"Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection","volume":"43","author":"Pannaraj","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C125","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/BPO.0b013e318186eb4b","article-title":"The impact of the current epidemiology of pediatric musculoskeletal infection on evaluation and treatment guidelines","volume":"28","author":"Gafur","year":"2008","journal-title":"J Pediatr Orthop"},{"key":"2020120907532979700_CIU296C126","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.amjmed.2004.03.031","article-title":"Bacterial pyomyositis in the United States","volume":"117","author":"Crum","year":"2004","journal-title":"Am J Med"},{"key":"2020120907532979700_CIU296C127","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10096-007-0283-7","article-title":"Streptococcus pneumoniae skin and soft tissue infections: characterization of causative strains and clinical illness","volume":"26","author":"Garcia-Lechuz","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020120907532979700_CIU296C128","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10140-007-0593-1","article-title":"MR imaging findings of pyogenic bacterial myositis (pyomyositis) in patients with local muscle trauma: illustrative cases","volume":"14","author":"Theodorou","year":"2007","journal-title":"Emerg Radiol"},{"key":"2020120907532979700_CIU296C129","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00256-009-0780-0","article-title":"Imaging of musculoskeletal soft tissue infections","volume":"39","author":"Turecki","year":"2010","journal-title":"Skeletal Radiol"},{"key":"2020120907532979700_CIU296C130","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00247-008-0888-8","article-title":"Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children","volume":"38","author":"Browne","year":"2008","journal-title":"Pediatr Radiol"},{"key":"2020120907532979700_CIU296C131","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1128\/JCM.02379-07","article-title":"Septic pulmonary emboli and bacteremia associated with deep tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus","volume":"46","author":"Lin","year":"2008","journal-title":"J Clin Microbiol"},{"key":"2020120907532979700_CIU296C132","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1128\/JCM.42.9.4050-4053.2004","article-title":"Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002","volume":"42","author":"Campbell","year":"2004","journal-title":"J Clin Microbiol"},{"key":"2020120907532979700_CIU296C133","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1128\/AAC.49.6.2260-2266.2005","article-title":"Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections","volume":"49","author":"Weigelt","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2020120907532979700_CIU296C134","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1086\/420818","article-title":"The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections","volume":"38","author":"Arbeit","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"suppl 3","key":"2020120907532979700_CIU296C135","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1093\/cid\/cis559","article-title":"Summary of ceftaroline fosamil clinical trials and clinical safety","author":"File","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C136","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.anaerobe.2011.11.001","article-title":"Life-threatening clostridial infections","volume":"18","author":"Stevens","year":"2012","journal-title":"Anaerobe"},{"key":"2020120907532979700_CIU296C137","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1128\/AAC.31.2.312","article-title":"Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens","volume":"31","author":"Stevens","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"2020120907532979700_CIU296C138","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/infdis\/155.2.220","article-title":"Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens","volume":"155","author":"Stevens","year":"1987","journal-title":"J Infect Dis"},{"key":"2020120907532979700_CIU296C139","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/clinids\/17.2.239","article-title":"Use of hyperbaric oxygen","volume":"17","author":"Heimbach","year":"1993","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C140","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0196-0644(80)80188-0","article-title":"Dog bite wounds and infection: a prospective clinical study","volume":"9","author":"Goldstein","year":"1980","journal-title":"Ann Emerg Med"},{"key":"2020120907532979700_CIU296C141","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1128\/AAC.32.8.1143","article-title":"Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds","volume":"32","author":"Goldstein","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"2020120907532979700_CIU296C142","first-page":"1","article-title":"General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Kroger","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"2020120907532979700_CIU296C143","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/jac\/48.5.641","article-title":"Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections","volume":"48","author":"Goldstein","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"2020120907532979700_CIU296C144","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/emj.6.4.251","article-title":"A comparative double blind study of amoxycillin\/clavulanate vs placebo in the prevention of infection after animal bites","volume":"6","author":"Brakenbury","year":"1989","journal-title":"Arch Emerg Med"},{"key":"2020120907532979700_CIU296C145","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/379331","article-title":"Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments","volume":"37","author":"Talan","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C146","first-page":"1","article-title":"Tetanus surveillance\u2014United States, 1998\u20132000","volume":"52","author":"Pascual","year":"2003","journal-title":"MMWR Surveill Summ"},{"key":"2020120907532979700_CIU296C147","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/clinids\/14.3.633","article-title":"Bite wounds and infection","volume":"14","author":"Goldstein","year":"1992","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C148","first-page":"769","article-title":"Office management of minor wounds","volume":"47","author":"Gouin","year":"2001","journal-title":"Can Fam Physician"},{"key":"2020120907532979700_CIU296C149","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0196-0644(80)80153-3","article-title":"Prophylactic antibiotics in common dog bite wounds: a controlled study","volume":"9","author":"Callaham","year":"1980","journal-title":"Ann Emerg Med"},{"key":"2020120907532979700_CIU296C150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0196-0644(82)80093-0","article-title":"Prophylactic oxacillin in dog bite wounds","volume":"11","author":"Elenbaas","year":"1982","journal-title":"Ann Emerg Med"},{"key":"2020120907532979700_CIU296C151","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00006565-199208000-00005","article-title":"Prophylactic oral antibiotics for low-risk dog bite wounds","volume":"8","author":"Dire","year":"1992","journal-title":"Pediatr Emerg Care"},{"key":"2020120907532979700_CIU296C152","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0733-8627(20)30681-7","article-title":"Emergency management of dog and cat bite wounds","volume":"10","author":"Dire","year":"1992","journal-title":"Emerg Med Clin North Am"},{"key":"2020120907532979700_CIU296C153","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0196-0644(94)70073-7","article-title":"Antibiotics to prevent infection in patients with dog bite wounds: a meta-analysis of randomized trials","volume":"23","author":"Cummings","year":"1994","journal-title":"Ann Emerg Med"},{"key":"2020120907532979700_CIU296C154","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1056\/NEJMra0707253","article-title":"Current management of acute cutaneous wounds","volume":"359","author":"Singer","year":"2008","journal-title":"N Engl J Med"},{"key":"2020120907532979700_CIU296C155","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001738","article-title":"Antibiotic prophylaxis for mammalian bites","author":"Medeiros","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"2020120907532979700_CIU296C156","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1128\/jcm.8.6.667-672.1978","article-title":"Bacteriology of human and animal bite wounds","volume":"8","author":"Goldstein","year":"1978","journal-title":"J Clin Microbiol"},{"key":"2020120907532979700_CIU296C157","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/CMR.00041-10","article-title":"Microbiology of animal bite wound infections","volume":"24","author":"Abrahamian","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"2020120907532979700_CIU296C158","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1128\/AAC.32.2.213","article-title":"Lack of in vitro efficacy of oral forms of certain cephalosporins, erythromycin, and oxacillin against Pasteurella multocida","volume":"32","author":"Goldstein","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"2020120907532979700_CIU296C159","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1128\/AAC.43.6.1469","article-title":"Linezolid activity compared to those of selected macrolides and other agents against aerobic and anaerobic pathogens isolated from soft tissue bite infections in humans","volume":"43","author":"Goldstein","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"2020120907532979700_CIU296C160","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1128\/AAC.16.3.322","article-title":"Antibiotic susceptibilities of human isolates of Pasteurella multocida","volume":"16","author":"Stevens","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"2020120907532979700_CIU296C161","first-page":"1","article-title":"Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures. Recommendations of the Immunization Practices Advisory Committee (ACIP)","volume":"40","author":"No authors listed","year":"1991","journal-title":"MMWR Recomm Rep"},{"key":"2020120907532979700_CIU296C162","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0140-6736(05)65476-1","article-title":"Tetanus toxoid for adults\u2014too much of a good thing","volume":"348","author":"Bowie","year":"1996","journal-title":"Lancet"},{"key":"2020120907532979700_CIU296C163","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00005373-198003000-00010","article-title":"Successful treatment protocol for canine fang injuries","volume":"20","author":"Zook","year":"1980","journal-title":"J Trauma"},{"key":"2020120907532979700_CIU296C164","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/00006534-197205000-00003","article-title":"The treatment of dog bite injuries, especially those of the face","volume":"49","author":"Schultz","year":"1972","journal-title":"Plast Reconstr Surg"},{"key":"2020120907532979700_CIU296C165","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archotol.1990.01870070037006","article-title":"Management of animal and human bites in the head and neck","volume":"116","author":"Stucker","year":"1990","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"2020120907532979700_CIU296C166","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0007-1226(83)90051-6","article-title":"Dog bites of the face: a 15 year review","volume":"36","author":"Palmer","year":"1983","journal-title":"Br J Plast Surg"},{"key":"2020120907532979700_CIU296C167","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.281.18.1735","article-title":"Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense","volume":"281","author":"Inglesby","year":"1999","journal-title":"JAMA"},{"key":"2020120907532979700_CIU296C168","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199909093411107","article-title":"Anthrax","volume":"341","author":"Dixon","year":"1999","journal-title":"N Engl J Med"},{"key":"2020120907532979700_CIU296C169","first-page":"909","article-title":"Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001","volume":"50","author":"No authors listed","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020120907532979700_CIU296C170","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00006454-199806000-00002","article-title":"Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease","volume":"17","author":"Bass","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"2020120907532979700_CIU296C171","first-page":"46","article-title":"Bacillary angiomatosis: microbiology, histopathology, clinical presentation, diagnosis and management","volume":"88","author":"Ramirez Ramirez","year":"1996","journal-title":"Bol Asoc Med P R"},{"issue":"suppl 4","key":"2020120907532979700_CIU296C172","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00586-012-2289-9","article-title":"Empyema in spinal canal in thoracic region, abscesses in paravertebral space, spondylitis: in clinical course of zoonosis Erysipelothrix rhusiopathiae","volume":"21","author":"Andrychowski","year":"2012","journal-title":"Eur Spine J"},{"key":"2020120907532979700_CIU296C173","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1099\/00222615-48-9-789","article-title":"Erysipelothrix rhusiopathiae: bacteriology, epidemiology and clinical manifestations of an occupational pathogen","volume":"48","author":"Brooke","year":"1999","journal-title":"J Med Microbiol"},{"key":"2020120907532979700_CIU296C174","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1586\/eri.10.4","article-title":"Present and future therapeutic strategies for melioidosis and glanders","volume":"8","author":"Estes","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2020120907532979700_CIU296C175","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1056\/NEJM200107263450404","article-title":"Glanders in a military research microbiologist","volume":"345","author":"Srinivasan","year":"2001","journal-title":"N Engl J Med"},{"key":"2020120907532979700_CIU296C176","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis\u2014etiologic agent of plague","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"2020120907532979700_CIU296C177","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1093\/cid\/cir612","article-title":"Human tularemia in France, 2006\u20132010","volume":"53","author":"Maurin","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C178","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.sder.2007.09.002","article-title":"Approach to the patient with presumed cellulitis","volume":"26","author":"Kroshinsky","year":"2007","journal-title":"Semin Cutan Med Surg"},{"key":"2020120907532979700_CIU296C179","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0891-5520(05)70164-1","article-title":"Dermatologic infections in the immunocompromised (non-HIV) host","volume":"15","author":"Lopez","year":"2001","journal-title":"Infect Dis Clin North Am"},{"key":"2020120907532979700_CIU296C180","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJM199909163411207","article-title":"Fever in immunocompromised patients","volume":"341","author":"Pizzo","year":"1999","journal-title":"N Engl J Med"},{"key":"2020120907532979700_CIU296C181","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.jaad.2010.09.732","article-title":"Cutaneous small-vessel vasculitis associated with solid organ malignancies: the Mayo Clinic experience, 1996 to 2009","volume":"66","author":"Podjasek","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"2020120907532979700_CIU296C182","article-title":"Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy","volume":"1","author":"Gafter-Gvili","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2020120907532979700_CIU296C183","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1086\/322733","article-title":"Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center","volume":"33","author":"Montoya","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C184","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1128\/JCM.00147-10","article-title":"Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia","volume":"48","author":"Lamoth","year":"2010","journal-title":"J Clin Microbiol"},{"key":"2020120907532979700_CIU296C185","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1086\/512818","article-title":"Detection and identification of microorganisms by gene amplification and sequencing","volume":"44","author":"Petti","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C186","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.cll.2013.03.009","article-title":"Invasive fungal infections: biomarkers and molecular approaches to diagnosis","volume":"33","author":"Schuetz","year":"2013","journal-title":"Clin Lab Med"},{"key":"2020120907532979700_CIU296C187","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C188","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1445-5994.2010.02338.x","article-title":"Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010\/2011. Australian Consensus Guidelines 2011 Steering Committee","volume":"41","author":"Lingaratnam","year":"2011","journal-title":"Intern Med J"},{"key":"2020120907532979700_CIU296C189","doi-asserted-by":"crossref","first-page":"122","DOI":"10.6004\/jnccn.2008.0013","article-title":"Prevention and treatment of cancer-related infections","volume":"6","author":"Segal","year":"2008","journal-title":"J Natl Compr Canc Netw"},{"key":"2020120907532979700_CIU296C190","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/bmt.2009.254","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface","volume":"44","author":"Tomblyn","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"2020120907532979700_CIU296C191","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C192","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C193","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C194","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/CCM.0b013e31822b50c2","article-title":"Survival in neutropenic patients with severe sepsis or septic shock","volume":"40","author":"Legrand","year":"2012","journal-title":"Crit Care Med"},{"key":"2020120907532979700_CIU296C195","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00520-010-0925-7","article-title":"Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?","volume":"19","author":"Paesmans","year":"2011","journal-title":"Support Care Cancer"},{"key":"2020120907532979700_CIU296C196","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1200\/JCO.2005.03.9909","article-title":"Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications","volume":"24","author":"Klastersky","year":"2006","journal-title":"J Clin Oncol"},{"key":"2020120907532979700_CIU296C197","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/MCP.0b013e328351f8e8","article-title":"Bacterial lung sepsis in patients with febrile neutropenia","volume":"18","author":"Lanoix","year":"2012","journal-title":"Curr Opin Pulm Med"},{"key":"2020120907532979700_CIU296C198","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/IDR.S11413","article-title":"Long-term epidemiology of bacterial susceptibility profiles in adults suffering from febrile neutropenia with hematologic malignancy after antibiotic change","volume":"3","author":"Mebis","year":"2010","journal-title":"Infect Drug Resist"},{"key":"2020120907532979700_CIU296C199","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1473-3099(09)70054-4","article-title":"The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria","volume":"9","author":"Nordmann","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"2020120907532979700_CIU296C200","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00043426-200110000-00010","article-title":"Deep soft tissue infections in the neutropenic pediatric oncology patient","volume":"23","author":"Johnston","year":"2001","journal-title":"J Pediatr Hematol Oncol"},{"key":"2020120907532979700_CIU296C201","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/j.jaad.2003.09.019","article-title":"Nonpseudomonal ecthyma gangrenosum","volume":"50","author":"Reich","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"2020120907532979700_CIU296C202","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/asheducation-2006.1.368","article-title":"Viral infections in patients with hematological malignancies","volume":"2006","author":"Wade","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2020120907532979700_CIU296C203","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM199305063281808","article-title":"Management of fever in patients with cancer and treatment-induced neutropenia","volume":"328","author":"Pizzo","year":"1993","journal-title":"N Engl J Med"},{"key":"2020120907532979700_CIU296C204","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3109\/10428194.2011.602770","article-title":"Management of gram-positive bacterial infections in patients with cancer","volume":"53","author":"Kosmidis","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"2020120907532979700_CIU296C205","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/504431","article-title":"What can we learn from studies comparing linezolid with vancomycin in neutropenic patients when vancomycin dosages are not optimized?","volume":"42","author":"Tattevin","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C206","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1086\/500139","article-title":"Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer","volume":"42","author":"Jaksic","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C207","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJM199907293410501","article-title":"A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy","volume":"341","author":"Freifeld","year":"1999","journal-title":"N Engl J Med"},{"key":"2020120907532979700_CIU296C208","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1200\/JCO.2011.37.5758","article-title":"No place like home? Outpatient management of patients with febrile neutropenia and low risk","volume":"29","author":"Freifeld","year":"2011","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"2020120907532979700_CIU296C209","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1093\/cid\/cir885","article-title":"Combination therapy for mucormycosis: why, what, and how?","volume":"54","author":"Spellberg","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C210","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/1097-0142(19870215)59:4<844::AID-CNCR2820590431>3.0.CO;2-U","article-title":"Differences between first and subsequent fevers during prolonged neutropenia","volume":"59","author":"Wingard","year":"1987","journal-title":"Cancer"},{"key":"2020120907532979700_CIU296C211","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0889-8588(18)30268-5","article-title":"Management of infection in patients with acute leukemia","volume":"7","author":"Wade","year":"1993","journal-title":"Hematol Oncol Clin North Am"},{"key":"2020120907532979700_CIU296C212","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007394","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromized patients","volume":"4","author":"Leeflang","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"suppl 1","key":"2020120907532979700_CIU296C213","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1439-0507.2007.01375.x","article-title":"Advances in the serological diagnosis of invasive Aspergillus infections in patients with haematological disorders","volume":"50","author":"Maertens","year":"2007","journal-title":"Mycoses"},{"key":"2020120907532979700_CIU296C214","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1086\/510677","article-title":"Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts","volume":"44","author":"Segal","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00128071-200607010-00004","article-title":"Cutaneous fungal infections in the oncology patient: recognition and management","volume":"7","author":"Mays","year":"2006","journal-title":"Am J Clin Dermatol"},{"key":"2020120907532979700_CIU296C216","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/infdis\/164.4.731","article-title":"Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation","volume":"164","author":"Goodrich","year":"1991","journal-title":"J Infect Dis"},{"key":"2020120907532979700_CIU296C217","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/jama.1974.03230490054025","article-title":"Skin lesions associated with disseminated candidiasis","volume":"229","author":"Bodey","year":"1974","journal-title":"JAMA"},{"key":"2020120907532979700_CIU296C218","doi-asserted-by":"crossref","first-page":"539","DOI":"10.7326\/0003-4819-91-4-539","article-title":"Candida tropicalis: a major pathogen in immunocompromised patients","volume":"91","author":"Wingard","year":"1979","journal-title":"Ann Intern Med"},{"key":"2020120907532979700_CIU296C219","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archinte.1978.03630280026013","article-title":"Fever, rash, and muscle tenderness. A distinctive clinical presentation of disseminated candidiasis","volume":"138","author":"Jarowski","year":"1978","journal-title":"Arch Intern Med"},{"key":"2020120907532979700_CIU296C220","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00005792-198607000-00005","article-title":"Trichosporonosis in patients with neoplastic disease","volume":"65","author":"Walsh","year":"1986","journal-title":"Medicine"},{"key":"2020120907532979700_CIU296C221","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198710293171802","article-title":"Primary cutaneous aspergillosis associated with Hickman intravenous catheters","volume":"317","author":"Allo","year":"1987","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"2020120907532979700_CIU296C222","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C223","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C224","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/313918","article-title":"Significance of aspergillemia in patients with cancer: a 10-year study","volume":"31","author":"Kontoyiannis","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C225","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM197811162992007","article-title":"Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment","volume":"299","author":"Gartenberg","year":"1978","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"2020120907532979700_CIU296C226","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1093\/clinids\/14.Supplement_1.S43","article-title":"Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review","volume":"14","author":"Anaissie","year":"1992","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C227","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00014-07","article-title":"Fusarium infections in immunocompromised patients","volume":"20","author":"Nucci","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"2020120907532979700_CIU296C228","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/420746","article-title":"Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients","volume":"38","author":"Doucette","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C229","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2020120907532979700_CIU296C230","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s15010-009-9193-9","article-title":"Nocardiosis: updated clinical review and experience at a tertiary center","volume":"38","author":"Ambrosioni","year":"2010","journal-title":"Infection"},{"key":"2020120907532979700_CIU296C231","first-page":"127","article-title":"Primary cutaneous aspergillosis in a patient with a solid organ transplant: case report and review of the literature","volume":"81","author":"Thomas","year":"2008","journal-title":"Cutis"},{"issue":"suppl 1","key":"2020120907532979700_CIU296C232","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0560.2008.01208.x","article-title":"Scedosporium apiospermum: an emerging opportunistic pathogen that must be distinguished from Aspergillus and other hyalohyphomycetes","volume":"36","author":"Shinohara","year":"2009","journal-title":"J Cutan Pathol"},{"key":"2020120907532979700_CIU296C233","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1346-8138.2005.tb00761.x","article-title":"Cutaneous mucormycosis in a patient with acute lymphocytic leukemia","volume":"32","author":"Miyamoto","year":"2005","journal-title":"J Dermatol"},{"key":"2020120907532979700_CIU296C234","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.transproceed.2010.01.004","article-title":"Cellulitis and nodular skin lesions due to Fusarium spp in liver transplant: case report","volume":"42","author":"Halpern","year":"2010","journal-title":"Transplant Proc"},{"key":"2020120907532979700_CIU296C235","first-page":"303","article-title":"Cryptococcal panniculitis in an immunocompromised patient: a case report and review of the literature","volume":"85","author":"Abuav","year":"2010","journal-title":"Cutis"},{"key":"2020120907532979700_CIU296C236","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C237","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1086\/521259","article-title":"Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America","volume":"45","author":"Wheat","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2020120907532979700_CIU296C238","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/MOT.0b013e3283329c9a","article-title":"Histoplasmosis in solid organ transplant recipients: early diagnosis and treatment","volume":"14","author":"Freifeld","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"2020120907532979700_CIU296C239","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.idc.2010.01.003","article-title":"Herpes viruses in transplant recipients: HSV, VZV, human herpes viruses, and EBV","volume":"24","author":"Shiley","year":"2010","journal-title":"Infect Dis Clin North Am"},{"key":"2020120907532979700_CIU296C240","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood-2007-03-077644","article-title":"One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation","volume":"110","author":"Erard","year":"2007","journal-title":"Blood"},{"key":"2020120907532979700_CIU296C241","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1086\/518938","article-title":"Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV disease","volume":"196","author":"Erard","year":"2007","journal-title":"J Infect Dis"},{"key":"2020120907532979700_CIU296C242","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaad.2009.09.037","article-title":"Disseminated Strongyloides stercoralis: hyperinfection during medical immunosuppression","volume":"63","author":"Basile","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"2020120907532979700_CIU296C243","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1399-3062.2006.00159.x","article-title":"A case of successful treatment of cutaneous Acanthamoeba infection in a lung transplant recipient","volume":"9","author":"Walia","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"2020120907532979700_CIU296C244","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.healun.2009.08.006","article-title":"Infections in heart transplant recipients in Brazil: the challenge of Chagas\u2019 disease","volume":"29","author":"Godoy","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"2020120907532979700_CIU296C245","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1346-8138.2003.tb00440.x","article-title":"The pattern of mucocutaneous infections and infestations in renal transplant recipients","volume":"30","author":"Sandhu","year":"2003","journal-title":"J Dermatol"},{"key":"2020120907532979700_CIU296C246","volume-title":"Committee on Infectious Diseases, American Academy of Pediatrics. Antimicrobial agents and related therapy","author":"Pickering","year":"2003","edition":"26th ed"},{"key":"2020120907532979700_CIU296C247","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/cid\/cis437","article-title":"Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections","volume":"55","author":"Pascual","year":"2012","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/59\/2\/e10\/34831424\/ciu296.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/59\/2\/e10\/34831424\/ciu296.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T18:26:23Z","timestamp":1716834383000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/59\/2\/e10\/2895845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,15]]},"references-count":247,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,7,15]]},"published-print":{"date-parts":[[2014,7,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciu296","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,7,15]]},"published":{"date-parts":[[2014,7,15]]}}}